The roots of Prophesee’s technology run deep into areas of significant achievements in vision, including the breakthrough research carried out by the Vision Institute (CNRS, UPMC, INSERM) on the human brain and eye during the past 20 years, as well as by CERN, where it was instrumental in the discovery of the invisible Higgs Boson, or “The God Particle” in 2012 after more than 30 years of research. Early incarnations of the Prophesee technology helped in the development of the first industry-grade silicon retina which is currently deployed to restore sight to the blind.
Thanks to its fast vision processing equivalent to up to 100,000 fps, Prophesee’s bio-inspired technology enables machines to capture scene changes not previously possible in machine vision systems for robotics, industrial automation and automotive.
Its HDR of more than 120dB lets systems operate and adapt effectively in a wide range of lighting conditions. It sets a new standard for power efficiency with operating characteristics of less than 10mW, opening new types of applications and use models for mobile, wearable and remote vision-enabled products.
“Our event-based approach to vision sensing and processing has resonated well with our customers in the automotive, industrial and IoT sectors, and the technology continues to achieve impressive results in benchmarking and prototyping exercises. This latest round of financing will help us move rapidly from technology development to market deployment,” said Luca Verre, co-founder and CEO of Prophesee. “Having the backing of our original investors, plus a world leader in electronics and consumer devices, further strengthens our strategy and will help Prophesee win the many market opportunities we are seeing.”
![]() |
Prophesee AI-based neuromorphic vision sensor |
0 Response to "Chronocan Changes Name to Prophesee, Raises More Money"
Post a Comment